2nd Annual Innovative Pharma Pricing & Market Access Strategies

We are pleased to invite you to the 2nd Annual Innovative Pharma Pricing & Market Access Strategies Summit on February 15th – 16th, 2018.

This Summit will bring together industry leaders and experts to discuss the latest findings, best practices, and newest technologies in relation to Pharma Pricing & Market Access. Industry professionals will be seeking answers to some of the field’s biggest challenges including: increasing access to the market, pursuing innovation, and learning how to take smart risks when engaging with the market. Attendees will have the opportunity to learn from these experts and network with them to make practical solutions and evolvements in Pharma Pricing & Market Access.

It is an honour to host the 2nd edition to this summit, and it’s a privilege to invite you to partake. We look forward to your participation in February!

Key Practical Learning Points of the Summit:

  • The impact of pricing policies on Pharmaceutical Innovation
  • Biosimilars and their influence on pricing and reimbursement
  • Pricing strategy: Price premiums vs discounts: What’s best?
  • Balancing value & affordability for a new orphan product
  • Improving value proposition with HTA
  • Development of alternative payment models
  • Persuading payers for expensive new treatments with RWE
  • Fostering a successful tendering management strategy
  • Ensuring market access success
  • Maximizing your market access strategies by knowing regulatory trends
  • Patient-centered approaches that help advance market access goals
  • The contribution of marketing intelligence to pharmaceutical market access

Who Should Attend:

CEOs / Presidents / MDs, CCOs/CMOs/CDOs, Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Business Development
  • Marketing
  • Sales
  • Pricing
  • Market Access
  • Medical Director
  • Marketing Intelligence
  • Drug Pricing
  • Product Launch
  • Health Economics
  • Pricing Policy
  • Product Reimbursement
  • Health Technology Assessment
  • Real World Evidence
  • Health Informatics
  • Data Sciences
  • Value Strategy
  • P&MA
  • Tendering

From Industries Including:

  • Biotechnology
  • Pharmaceuticals
Media partners